nach oben

Erschienen in:

2011 | OriginalPaper | Buchkapitel

20. Kreislauftherapie

verfasst von : Prof. Dr. Thomas Möllhoff, Prof. Dr. Elmar Berendes

Erschienen in: Pharmakotherapie in der Anästhesie und Intensivmedizin

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Der Einsatz vasoaktiver Substanzen in Anästhesie und Intensivmedizin nimmt einen immer höheren Stellenwert ein, da die perioperative Betreuung von Hochrisikopatiten mit multiplen Vorerkrankungen nicht mehr die Ausnahme darstellt. Insbesondere in der Intensivmedizin s len heute dielherapie von akutem Herzversagen, SIRS t Sepsis mit allen Komplikationen bis hin zum Multiorgversagen eine besondere Herausforderung dar. Damit bekommt die komplexe Diagnostik und Behandlung des Herz-Kreislauf Versagens eine große Bedeutung in der täglichen Arbeit des Anästhesisten und Intensivmediziners.

[1]

Ahlquist R (1948) A study of the adrenotropic receptors. Am J Physiol 153:586–600PubMed

[2]

Annane D, Vignon P, Renault A et al. (2007) Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 370: 676–684PubMedCrossRef

[3]

Berendes E, Möllhoff X van Aken H et al. (1997) Effects of dopexamine on creatinine clearance, systemic inflammation, and splanchnic oxygenation in patients undergoing coronary artery bypass grafting. Anesth Anal 84:950–957

[4]

Dellinger R, Levy M, Carlet J et al. (2008) Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296–327PubMedCrossRef

[5]

Butterworth J (1993) Selecting an inotrope for the cardiac surgery patient. Journal of cardiothoracic and vascular Anesthesia 7: 26–32PubMedCrossRef

[6]

Butterworth J, Prielipp R, Royster R et al. (1992) Dobutamine increases heart rate more than epinephrine in patients recovering from aortocoronary bypass surgery. J Cardiothoracic Vase Anesth 6:535–541CrossRef

[7]

Carl M, Alms A, Braun J et al. (2006) S3-Leitlinie zur intensivmedizinischen Versorgung herzchirurgischer Patienten. Hämodynamisches Monitoring und Herz-Kreislauf,www.awmf.org1:1–194

[8]

Cummins Ro, Hazinski Mf (2000) Advanced Cardiovascular Life Support. Section 6: Pharmacology II: Agents to Optimize Cardiac Output and Blood Pressure. Circulation 102:1129–1135

[9]

de Backer D, Creteur J, Silva E, Vincent JL (2003) Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: Which is best? Crit Care Med 31: 1659–1667PubMedCrossRef

[10]

de Backer D, Biston P, Devriendt J et al. (2010) Comparison of Dopamine and Norepinephrine in the Treatment of Shock. NEJM 362:779–789PubMedCrossRef

[11]

Dellinger RP, Levy MM, Carlet Jm (2008) Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic schock: 2008. Crit Care Med 36:296–327PubMedCrossRef

[12]

Duke G, Briedis J, Weaver R (1994) Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine? [see comments]. Crit Care Med 22:1919–1925PubMed

[13]

Feneck R (1992) Intravenous milrinone following cardiac surgery: I. Effects of bolus infusion followed by variable dose maintenance infusion. The European Milrinone Multicentre Trial Group. J Cardiothoracic Vase Anesth 6:554–562CrossRef

[14]

Feneck R (1992) Intravenous milrinone following cardiac surgery: I. Influence of baseline hemodynamics and patient factors on therapeutic response. The European Milrinone Multicentre Trial Group. J Cardiothoracic Vase Anesth 6:563–567CrossRef

[15]

Flancbaum L, Choban P, Dasta J (1994) Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients [see comments]. Crit Care Med 22:61–68PubMed

[16]

Follath F, Cleland J, Just H et al. (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360:196–202PubMedCrossRef

[17]

Fullerton D, Cyr J, Albert J et al. (1993) Hemodynamic advantage of left atrial epinephrine administration after cardiac operations. Ann Thoracic Surg 56:1263–1266CrossRef

[18]

Gunnicker M, Brinkmann M, Donovan T et al. (1995) The efficacy of amrinone or adrenaline on low cardiac output following cardiopulmonary bypass in patients with coronary artery disease undergoing preoperative beta-blockade. Thorac Cardiovasc Surg 43:153–160PubMedCrossRef

[19]

Hachenberg T, MöllhoffX T, Holst D et al. (1997) Cardiopulmonary effects of enoximone or dobutamine and nitroglycerin on mitral valve regurgitation and pulmonary venous hypertension. J Cardiothoracic Vase Anesth 11:453–457CrossRef

[20]

Haikala H, Levijoki J, Linden I (1995)Troponin C-mediated calcium sensitization by levosimendan accelerates the proportional development of isometric tension. J Mol Cell Cardiol 27: 2155–2165PubMedCrossRef

[21]

Hardy J, Searle N, Roy M et al. (1993) Amrinone, in combination with norepinephrine, is an effective first-line drug for difficult separation from cardiopulmonary bypass. Can J Anaesth 40: 495–501PubMedCrossRef

[22]

Hasenfuss G, Pieske B, Castell M et al. (1998) Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation 98: 2141–2147PubMedCrossRef

[23]

Ho R, Sutherland E (1975) Action of feedback regulator on adenylate cyclase. Proceedings of the National Academy of Sciences of the United States of America 72:1773–1777PubMedCrossRef

[24]

Ho R, Sutherland E (1975) cAMP-mediated feedback regulation in target cells. Adv Cycl Nucleotide Res 5:533–548

[25]

Honkonen E, Kaukinen L, Kaukinen S et al. (1998) Dopexamine unloads the impaired right ventricle better than iloprost, a prostacyclin analog, after coronary artery surgery. J Cardiothoracic Vase Anesth 12:647–653CrossRef

[26]

Janssen P, Datz N, Zeitz O et al. (2000) Levosimendan improves diastolic and systolic function in failing human myocardium. Europ J Pharmacol 404:191–199CrossRef

[27]

Jenkins I, Dolman J, O'connor J et al. (1997) Amrinone versus dobutamine in cardiac surgical patients with severe pulmonary hypertension after cardiopulmonary bypass: a prospective, randomized double-blinded trial. Anaesth Int Care 25:245–249

[28]

Kelleher R, Rose A, Ordway L (1991) Prostaglandins for the control of pulmonary hypertension in the postoperative cardiac surgery patient: nursing implications. Crit Care Nurs Clin North Am 3:741–748PubMed

[29]

Kerins D, Murray R, Fitzgerald G (1991) Prostacyclin and prostaglandin El: molecular mechanisms and therapeutic utility. Prog HemostThromb 10:307–337

[30]

Kieler Jensen N, Houltz E, Ricksten S (1995) A comparison of prostacyclin and sodium nitroprusside for the treatment of heart failure after cardiac surgery. J Cardiothoracic Vase Anesth 9:641–646CrossRef

[31]

Kivikko M, Lehtonen L, Colucci W (2003) Sustained hemodynamic effects of intravenous levosimendan. Circulation 107: 81–86PubMedCrossRef

[32]

Lands A, Arnold A, Mcauliff J et al. (1967) Differentiation of receptor systems activated by sympathomimetic amines. Nature 214: 597–598PubMedCrossRef

[33]

Le Tulzo Y, Seguin P, Gacouin A et al. (1997) Effects of epinephrine on right ventricular function in patients with severe septic shock and right ventricular failure: a preliminary descriptive study. Int Care Med 23:664–670CrossRef

[34]

Lee R, Neya K, Svizzero T et al. (1995) Norepinephrine infusion following cardiopulmonary bypass: effect of infusion site. J Surg Research 58:143–148CrossRef

[35]

Levy B, Bollaert P, Charpentier C et al. (1997) Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Int Care Med 23: 282–287CrossRef

[36]

Levy J (2010) Treating Shock-Old Drugs-New Ideas. NEJM 362: 841–843PubMedCrossRef

[37]

Loick Hm, Möllhoff X Berendes E et al. (1997) Influence of enoximone on systemic and splanchnic oxygen utilization and endotoxin release following cardiopulmonary bypass. Int Care Med 23:267–275CrossRef

[38]

Macgregor D, Butterworth J, Zaloga C et al. (1994) Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting. Chest 106:835–841PubMedCrossRef

[39]

Mcghie A, Golstein R (1992) Pathogenesis and management of acute heart failure and cardiogenic shock: role of inotropic therapy. Chest 102:626s–632sPubMedCrossRef

[40]

Mebazaa A, Nieminen M, Packer M et al. (2007) Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 297:1883–1891PubMedCrossRef

[41]

Meier Hellmann A, Bredle DI, Specht M et al. (1997) The effects of low-dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock. Int Care Med 23:31–37CrossRef

[42]

Möllhoff T (2000) Einsatz hämodynamisch aktiver Substanzen bei Erwachsenen in der Kardiochirurgie. Anästhesiol Intensivmed 41:577–584

[43]

Möllhoff T, Loick Hm, van Aken H et al. (1999) Milrinone modulates endotoxemia, systemic inflammation, and subsequent acute phase response after cardiopulmonary bypass (CPB). Anesthesiology 90:72–80PubMedCrossRef

[44]

Möllhoff T, Rosiers P, van Aken H (1990) Urapidil, sodium nitroprusside and nitroglycerin. Effects on haemodynamics, venous admixture and arterial oxygenation after coronary artery bypass grafting. Drugs 40:73–76PubMedCrossRef

[45]

Myburgh J, Higgins A, Jovanovska A, et al. (2008) A comparison of epinephrine and norepinephrine in critically ill patients. Int Care Med 34:2226–2234CrossRef

[46]

Nacul F, Guia I, Lessa M,Tibrica E (2010): The effects of vasoactive drugs on intestinal functional capillary density in endotoxemic rats: Intravital video-microscopy analysis. Anesth Analg 110: 547–554PubMedCrossRef

[47]

Nieminen M, Böhm M, Cowie M et al. (2005) Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Europ Heart J 26:384–416CrossRef

[48]

Petry A, Dutschke P, Regensburger D (1996) Effects of enoximone on right-ventricular function in patients with impaired myocardial performance. Thorac Cardiovasc Surg 44:173–177PubMedCrossRef

[49]

Prielipp R, Macgregor D, Royster R et al. (1998) Dobutamine antagonizes epinephrine's biochemical and cardiotonic effects: results of an in vitro model using human lymphocytes and a clinical study in patients recovering from cardiac surgery. Anest-hesiology 89:49–57CrossRef

[50]

Prielipp R, McLear R, Rosenthal M et al. (1991) Hemodynamic profiles of prostaglandin El, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension. Crit Care Med 19:60–67PubMedCrossRef

[51]

Puttonen J, Laine T, Ramela M et al. (2007) Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men. Eur J Pharm Sci 32: 271–277PubMedCrossRef

[52]

Rathmell J, Prielipp R, Butterworth J et al. (1998) A multicenter, randomized, blind comparison of amrinone with milrinone after elective cardiac surgery. Anesth Analg 86: 683–690PubMed

[53]

Royster R, Butterworth J, Prielipp R et al. (1993) Combined inotropic effects of amrinone and epinephrine after cardiopulmonary bypass in humans. Anesth Analg 77:662–672PubMedCrossRef

[54]

Russell I, Zwass M, Fineman J et al. (1998) The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesth Analg 87:46–51PubMed

[55]

Russell J, Walley K, Singer J et al. (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. NEJM 358: 877–887PubMedCrossRef

[56]

Schilling T, Gründling M, Moritz Ku et al. (2000) A Comparison of Equipotent Doses of Dopamine, Dobutamine or Dopexamine on Prolactin Release in High Risk Surgical Patients. Anesthesiol 93: A227CrossRef

[57]

Slawsky M, Colucci W, Gottlieb S et al. (2000) Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation 102:2222–2227PubMedCrossRef

[58]

Szabo G, Batkai S, Bahrle S et al. (1998) Effects of nitric oxide synthesis on reperfusion injury and catecholamine responsiveness in a heterotopic rat heart-transplantation model. J Cardiovasc Pharmacol 31:221–230PubMedCrossRef

[59]

van Den Berghe G, De Zegher F, Vlasselaers D et al. (1996) Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations. Crit Care Med 24:590–595PubMedCrossRef

[60]

Vendegna T, Anderson R (1994) Are dopamine and/or dobutamine renoprotective in intensive care unit patients? Crit Care Med 22:1893–1894PubMed

[61]

Vincent J (1994) Renal effects of dopamine: can our dream ever come true? Crit Care Med 22:5–6PubMedCrossRef

[62]

Wenzel V, Krismer A, Arntz H et al. (2004) A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. NEJM 350:105–113PubMedCrossRef

[63]

Westphal K, Martens S, Strouhal U et al. (1998) Nitric oxide inhalation in acute pulmonary hypertension after cardiac surgery reduces oxygen concentration and improves mechanical ventilation but not mortality. Thorac Cardiovasc Surg 46:70–73PubMedCrossRef

[64]

Westphal M, Van Aken H, Möllhoff T, Sielenkämper A (2005) Rationaler Einsatz vasoaktiver Substanzen bei Sepsis. Anästhesiol Intensivmed 46:431–445

[65]

Zwissler B (2000) Das akute Rechtsherzversagen. Anaesthesist 49:788–808PubMedCrossRef

[66]

Zwissler B, Rank N, Jaenicke U et al. (1995) Selective pulmonary vasodilation by inhaled prostacyclin in a newborn with congenital heart disease and cardiopulmonary bypass. Anesthesiol 82: 1512–1516CrossRef

Titel: Kreislauftherapie
verfasst von: Prof. Dr. Thomas Möllhoff
Prof. Dr. Elmar Berendes
Verlag: Springer Berlin Heidelberg
Buch: Pharmakotherapie in der Anästhesie und Intensivmedizin
Print ISBN: 978-3-540-79155-3

Electronic ISBN: 978-3-540-79156-0

Copyright-Jahr: 2011
DOI: https://doi.org/10.1007/978-3-540-79156-0_20

Neu im Fachgebiet AINS

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

20. Kreislauftherapie

Zusammenfassung

Neu im Fachgebiet AINS

Magen-Darm-Blutungen werden präklinisch oft falsch eingeschätzt

Sepsis-Verdacht: Eine Stunde, fünf essenzielle Maßnahmen

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Update AINS

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet AINS

Magen-Darm-Blutungen werden präklinisch oft falsch eingeschätzt

Sepsis-Verdacht: Eine Stunde, fünf essenzielle Maßnahmen

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Update AINS